L. Lehtiö
- Physiology top 1%
- Calcium signaling and nucleotide metabolism 13
- Oncology top 2%
- PARP inhibition in cancer therapy 49
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer 17
- DNA Repair Mechanisms 15
- Cancer-related gene regulation 9
- Protein Structure and Dynamics 7
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins 29
- Cell Biology top 10%
-
- Enzyme Structure and Function 18
- Co-authors
- T. HaikarainenStefan KraußMohit NarwalHarikanth VenkannagariH. SchülerEzeogo ObajiT. KarlbergAdrian Goldman
- Cited by
- PhysiologyOncologyMolecular Biology
- Journals
- Journal of Medicinal Chemistry (12 papers)Journal of Biological Chemistry (8 papers)PLoS ONE (7 papers)
- Partner nations
- FinlandUnited KingdomGermany
In The Last Decade
L. Lehtiö
99 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 107
- Physiology 219
- Oncology 1.1k
- Molecular Biology 2.0k
- Immunology 587
- Cell Biology 213
Countries citing papers authored by L. Lehtiö
This map shows the geographic impact of L. Lehtiö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lehtiö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lehtiö more than expected).
Fields of papers citing papers by L. Lehtiö
This network shows the impact of papers produced by L. Lehtiö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lehtiö. The network helps show where L. Lehtiö may publish in the future.
Co-authorship network
The 25 scholars most cited alongside L. Lehtiö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 13 | |
| 12 | Macrodomain binding compound MRS 2578 inhibits alphavirus replication | 2021 | 2 |
| 13 | 2021 | 6 | |
| 14 | 2021 | 25 | |
| 15 | 2021 | 48 | |
| 16 | 2021 | 10 | |
| 17 | 2020 | 26 | |
| 18 | 2020 | 13 | |
| 19 | 2020 | 11 | |
| 20 | 2018 | 19 |
About L. Lehtiö
L. Lehtiö is a scholar working on Physiology, Oncology, Immunology, Molecular Biology and Toxicology, having authored 104 papers that have together received 3.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (49 papers), Toxin Mechanisms and Immunotoxins (29 papers), Enzyme Structure and Function (18 papers), Wnt/β-catenin signaling in development and cancer (17 papers), DNA Repair Mechanisms (15 papers), Calcium signaling and nucleotide metabolism (13 papers), Cancer-related gene regulation (9 papers) and Protein Structure and Dynamics (7 papers). The work is most often cited by research in Physiology (219 citations), Oncology (1.1k citations), Molecular Biology (2.0k citations), Immunology (587 citations) and Cell Biology (213 citations). L. Lehtiö has collaborated with scholars based in Finland, United Kingdom and Germany. Frequent co-authors include T. Haikarainen, Stefan Krauß, Mohit Narwal, Harikanth Venkannagari, H. Schüler, Ezeogo Obaji, T. Karlberg, Adrian Goldman, Nai‐Wen Chi and Mirko M. Maksimainen. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, PLoS ONE, Scientific Reports and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.